Literature DB >> 17874048

Increased expression of beta-defensin-2 and -3 during the development of autoimmune sialoadenitis in MRL/lpr mice.

Masato Saitoh1, Yoshihito Kurashige, Mami Yamazaki, Michiko Nishimura, Sumiko Nakamura, Daisuke Noro, Maiko Takeshima, Toshiya Arakawa, Taishin Takuma, Seiji Igarashi, Tohru Kaku, Takashi Inoue, Yoshihiro Abiko.   

Abstract

beta-Defensins (BD) are small cationic antimicrobial peptides that produced principally in the epithelial cells of a number of organs. The present study analyzed the expression patterns of BD-1, -2, and -3 during the development of sialoadenitis in MRL/lpr mice. Submandibular glands were dissected from MRL/lpr mice at 4, 8, 10, 12, 14, and 16 weeks of age. The expression of mouse (m) BD-1, -2, and -3 mRNAs was examined by RT-PCR and quantified using TaqMan real-time RT-PCR. No significant differences in the level of expression of mBD-1 were observed among mice of different ages. The level of expression of mBD-2 was significantly higher at 16 weeks than at 4 or 8 weeks. The expression level of mBD-3 was highest in 14-week-old mice and was significantly higher than in 4-week or 16-week-old animals. Immunohistochemical staining showed that BD-3 was clearly localized in the ductal cells with variable intensities. In the center of the foci of lymphatic infiltration, ductal staining was faint or often not present. The results indicate that BD-2 and -3 may be upregulated during the development of autoimmune sialoadenitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17874048     DOI: 10.1007/s00795-007-0375-6

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  23 in total

1.  Expression of the antimicrobial peptide, human beta-defensin 1, in duct cells of minor salivary glands and detection in saliva.

Authors:  K S Sahasrabudhe; J R Kimball; T H Morton; A Weinberg; B A Dale
Journal:  J Dent Res       Date:  2000-09       Impact factor: 6.116

Review 2.  Salivary defensins and their importance in oral health and disease.

Authors:  Yoshihiro Abiko; Masato Saitoh
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

3.  Mouse beta defensin-1 is a functional homolog of human beta defensin-1.

Authors:  G M Morrison; D J Davidson; F M Kilanowski; D W Borthwick; K Crook; A I Maxwell; J R Govan; J R Dorin
Journal:  Mamm Genome       Date:  1998-06       Impact factor: 2.957

4.  The novel human beta-defensin-3 is widely expressed in oral tissues.

Authors:  Anton Dunsche; Yahya Açil; Henrik Dommisch; Reiner Siebert; Jens M Schröder; Søren Jepsen
Journal:  Eur J Oral Sci       Date:  2002-04       Impact factor: 2.612

5.  Lipopolysaccharide induced-in vivo increases in beta-defensins of the rat parotid gland.

Authors:  Malin Darnell; Hülya Cevik Aras; B Magnusson; J Ekström
Journal:  Arch Oral Biol       Date:  2006-05-15       Impact factor: 2.633

6.  Sjögren's syndrome in MRL/l and MRL/n mice.

Authors:  R W Hoffman; M A Alspaugh; K S Waggie; J B Durham; S E Walker
Journal:  Arthritis Rheum       Date:  1984-02

7.  Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms.

Authors:  Takashi Miwa; Michael A Maldonado; Lin Zhou; Koei Yamada; Gary S Gilkeson; Robert A Eisenberg; Wen-Chao Song
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

8.  Ultrastructural study of Sjögren's syndrome-like disease in MRL/l mice.

Authors:  A Tanaka; F X O'Sullivan; W J Koopman; S Gay
Journal:  J Oral Pathol       Date:  1988-11

9.  Effects of immunomodulating treatment on autoimmune sialadenitis in MRL/Mp-lpr/lpr mice.

Authors:  R Jonsson; A Tarkowski; K Bäckman
Journal:  Agents Actions       Date:  1988-12

Review 10.  Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways.

Authors:  F Rieux-Laucat; F Le Deist; A Fischer
Journal:  Cell Death Differ       Date:  2003-01       Impact factor: 15.828

View more
  2 in total

Review 1.  Role of beta-defensins in oral epithelial health and disease.

Authors:  Yoshihiro Abiko; Masto Saitoh; Michiko Nishimura; Mami Yamazaki; Daisuke Sawamura; Tohru Kaku
Journal:  Med Mol Morphol       Date:  2007-12-21       Impact factor: 2.309

2.  HBD-2 is downregulated in oral carcinoma cells by DNA hypermethylation, and increased expression of hBD-2 by DNA demethylation and gene transfection inhibits cell proliferation and invasion.

Authors:  Yoshitaka Kamino; Yoshihito Kurashige; Osamu Uehara; Jun Sato; Michiko Nishimura; Koki Yoshida; Toshiya Arakawa; Hiroki Nagayasu; Masato Saitoh; Yoshihiro Abiko
Journal:  Oncol Rep       Date:  2014-06-12       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.